Nomad Power Solutions, Inc. (NMAD)
3.46
-0.03
(-0.86%)
USD |
NASDAQ |
Nov 06, 10:20
Nomad Power Solutions Enterprise Value : 43.31M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 43.31M |
| November 04, 2026 | 45.01M |
| November 03, 2026 | 43.78M |
| November 02, 2026 | 43.01M |
| October 30, 2026 | 44.39M |
| October 29, 2026 | 44.09M |
| October 28, 2026 | 51.64M |
| October 27, 2026 | 50.25M |
| October 26, 2026 | 51.79M |
| October 23, 2026 | 48.25M |
| October 22, 2026 | 45.01M |
| October 21, 2026 | 43.93M |
| October 20, 2026 | 46.86M |
| October 19, 2026 | 47.02M |
| October 16, 2026 | 49.33M |
| October 15, 2026 | 52.57M |
| October 14, 2026 | 50.41M |
| October 13, 2026 | 55.49M |
| October 12, 2026 | 53.80M |
| October 09, 2026 | 59.35M |
| October 08, 2026 | 55.34M |
| October 07, 2026 | 55.03M |
| October 06, 2026 | 56.50M |
| October 05, 2026 | 51.41M |
| October 02, 2026 | 53.03M |
| Date | Value |
|---|---|
| October 01, 2026 | 49.02M |
| September 30, 2026 | 50.02M |
| September 29, 2026 | 47.32M |
| September 28, 2026 | 45.01M |
| September 25, 2026 | 44.70M |
| September 24, 2026 | 45.47M |
| September 23, 2026 | 43.85M |
| September 22, 2026 | 48.40M |
| September 21, 2026 | 46.24M |
| September 18, 2026 | 45.16M |
| September 17, 2026 | 45.16M |
| September 16, 2026 | 43.31M |
| September 15, 2026 | 41.31M |
| September 14, 2026 | 39.92M |
| September 11, 2026 | 44.09M |
| September 10, 2026 | 46.71M |
| September 09, 2026 | 46.71M |
| September 08, 2026 | 48.94M |
| September 04, 2026 | 51.64M |
| September 03, 2026 | 45.86M |
| September 02, 2026 | 46.71M |
| September 01, 2026 | 52.72M |
| August 31, 2026 | 53.34M |
| August 28, 2026 | 55.96M |
| August 27, 2026 | 57.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.737B |
| Alnylam Pharmaceuticals, Inc. | 20.38B |
| Anika Therapeutics, Inc. | 245.53M |
| Savara, Inc. | 757.02M |
| Vericel Corp. | 2.582B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.344M |
| Total Expenses (Quarterly) | 2.187M |
| EPS Diluted (Quarterly) | -0.1623 |
| Earnings Yield | -28.92% |
| Normalized Earnings Yield | -28.31 |